Heron Therapeutics, Inc. (HRTX): Cash & Equivalents
$28.65M
As of 2025-12-31
$20.72M
As of 2026-06-30
+23.1%
3-year compound annual growth
-22.9%
5-year compound annual growth
-9.2%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $28.65M | +11.0% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $25.80M | -10.0% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $28.68M | +86.7% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $15.36M | -83.0% | 2024-03-12, Balance as of period end |
| 2021-12-31 | $90.54M | -13.9% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $105.14M | +46.2% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $71.90M | +125.8% | 2021-02-24, Balance as of period end |
| 2018-12-31 | $31.84M | -78.0% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $144.58M | +977.9% | 2019-02-22, Balance as of period end |
| 2016-12-31 | $13.41M | -82.2% | 2019-02-22, Balance as of period end |
| 2015-12-31 | $75.18M | +3.4% | 2018-02-27, Balance as of period end |
| 2014-12-31 | $72.67M | +0.5% | 2017-02-23, Balance as of period end |
| 2013-12-31 | $72.29M | +35.1% | 2016-02-19, Balance as of period end |
| 2012-12-31 | $53.51M | +197.7% | 2015-03-13, Balance as of period end |
| 2011-12-31 | $17.97M | +752.3% | 2014-03-07, Balance as of period end |
| 2010-12-31 | $2.11M | -72.2% | 2013-03-01, Balance as of period end |
| 2009-12-31 | $7.59M | n/a | 2012-03-26, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $28.65M | +11.0% |
| Liquidia Corp (LQDA) | 2025-12-31 | $190.68M | +8.0% |
| Macrogenics Inc (MGNX) | 2025-12-31 | $57.22M | -68.7% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $60.54M | -3.1% |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | $134.93M | -12.4% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $129.97M | -56.3% |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $250.49M | +633.8% |
| Lifevantage Corp (LFVN) | 2025-06-30 | $20.20M | +19.6% |
| Stoke Therapeutics, Inc. (STOK) | 2025-12-31 | $84.22M | -34.2% |
Compare HRTX, LQDA, MGNX, KPTI side by side · Screen every company in Pharmaceutical Preparations ↗